Global Buspirone Market Growth 2023-2029

February 2023 | 108 pages | ID: G84FDB0B53EAEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Buspirone, sold under the brand name Buspar among others, is a medication primarily used to treat anxiety disorders, particularly generalized anxiety disorder. Benefits support its short term use. It has not been found to be effective in treating psychosis. It is taken by mouth, and it may take up to four weeks for an effect.

LPI (LP Information)' newest research report, the “Buspirone Industry Forecast” looks at past sales and reviews total world Buspirone sales in 2022, providing a comprehensive analysis by region and market sector of projected Buspirone sales for 2023 through 2029. With Buspirone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buspirone industry.

This Insight Report provides a comprehensive analysis of the global Buspirone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buspirone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Buspirone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buspirone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buspirone.

The global Buspirone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Buspirone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Buspirone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Buspirone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Buspirone players cover Bristol Myers Squibb, Apotex, Dr. Reddy's Laboratories, Laboratoires Servier, Teva, AMAG Pharmaceuticals, Mylan, Novartis and Watson Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Buspirone market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 5mg
• 10mg
• 15mg
• 30mg

Segmentation by application

• Hospital
• Drug Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bristol Myers Squibb
• Apotex
• Dr. Reddy's Laboratories
• Laboratoires Servier
• Teva
• AMAG Pharmaceuticals
• Mylan
• Novartis
• Watson Laboratories
• Hikma
• Wockhardt
• Cadila Healthcare
• Orion Corporation

Key Questions Addressed in this Report

What is the 10-year outlook for the global Buspirone market?

What factors are driving Buspirone market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Buspirone market opportunities vary by end market size?

How does Buspirone break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Buspirone Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Buspirone by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Buspirone by Country/Region, 2018, 2022 & 2029
2.2 Buspirone Segment by Type
  2.2.1 5mg
  2.2.2 10mg
  2.2.3 15mg
  2.2.4 30mg
2.3 Buspirone Sales by Type
  2.3.1 Global Buspirone Sales Market Share by Type (2018-2023)
  2.3.2 Global Buspirone Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Buspirone Sale Price by Type (2018-2023)
2.4 Buspirone Segment by Application
  2.4.1 Hospital
  2.4.2 Drug Store
2.5 Buspirone Sales by Application
  2.5.1 Global Buspirone Sale Market Share by Application (2018-2023)
  2.5.2 Global Buspirone Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Buspirone Sale Price by Application (2018-2023)

3 GLOBAL BUSPIRONE BY COMPANY

3.1 Global Buspirone Breakdown Data by Company
  3.1.1 Global Buspirone Annual Sales by Company (2018-2023)
  3.1.2 Global Buspirone Sales Market Share by Company (2018-2023)
3.2 Global Buspirone Annual Revenue by Company (2018-2023)
  3.2.1 Global Buspirone Revenue by Company (2018-2023)
  3.2.2 Global Buspirone Revenue Market Share by Company (2018-2023)
3.3 Global Buspirone Sale Price by Company
3.4 Key Manufacturers Buspirone Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Buspirone Product Location Distribution
  3.4.2 Players Buspirone Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR BUSPIRONE BY GEOGRAPHIC REGION

4.1 World Historic Buspirone Market Size by Geographic Region (2018-2023)
  4.1.1 Global Buspirone Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Buspirone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Buspirone Market Size by Country/Region (2018-2023)
  4.2.1 Global Buspirone Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Buspirone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Buspirone Sales Growth
4.4 APAC Buspirone Sales Growth
4.5 Europe Buspirone Sales Growth
4.6 Middle East & Africa Buspirone Sales Growth

5 AMERICAS

5.1 Americas Buspirone Sales by Country
  5.1.1 Americas Buspirone Sales by Country (2018-2023)
  5.1.2 Americas Buspirone Revenue by Country (2018-2023)
5.2 Americas Buspirone Sales by Type
5.3 Americas Buspirone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Buspirone Sales by Region
  6.1.1 APAC Buspirone Sales by Region (2018-2023)
  6.1.2 APAC Buspirone Revenue by Region (2018-2023)
6.2 APAC Buspirone Sales by Type
6.3 APAC Buspirone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Buspirone by Country
  7.1.1 Europe Buspirone Sales by Country (2018-2023)
  7.1.2 Europe Buspirone Revenue by Country (2018-2023)
7.2 Europe Buspirone Sales by Type
7.3 Europe Buspirone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Buspirone by Country
  8.1.1 Middle East & Africa Buspirone Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Buspirone Revenue by Country (2018-2023)
8.2 Middle East & Africa Buspirone Sales by Type
8.3 Middle East & Africa Buspirone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Buspirone
10.3 Manufacturing Process Analysis of Buspirone
10.4 Industry Chain Structure of Buspirone

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Buspirone Distributors
11.3 Buspirone Customer

12 WORLD FORECAST REVIEW FOR BUSPIRONE BY GEOGRAPHIC REGION

12.1 Global Buspirone Market Size Forecast by Region
  12.1.1 Global Buspirone Forecast by Region (2024-2029)
  12.1.2 Global Buspirone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Buspirone Forecast by Type
12.7 Global Buspirone Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Bristol Myers Squibb
  13.1.1 Bristol Myers Squibb Company Information
  13.1.2 Bristol Myers Squibb Buspirone Product Portfolios and Specifications
  13.1.3 Bristol Myers Squibb Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Bristol Myers Squibb Main Business Overview
  13.1.5 Bristol Myers Squibb Latest Developments
13.2 Apotex
  13.2.1 Apotex Company Information
  13.2.2 Apotex Buspirone Product Portfolios and Specifications
  13.2.3 Apotex Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Apotex Main Business Overview
  13.2.5 Apotex Latest Developments
13.3 Dr. Reddy's Laboratories
  13.3.1 Dr. Reddy's Laboratories Company Information
  13.3.2 Dr. Reddy's Laboratories Buspirone Product Portfolios and Specifications
  13.3.3 Dr. Reddy's Laboratories Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Dr. Reddy's Laboratories Main Business Overview
  13.3.5 Dr. Reddy's Laboratories Latest Developments
13.4 Laboratoires Servier
  13.4.1 Laboratoires Servier Company Information
  13.4.2 Laboratoires Servier Buspirone Product Portfolios and Specifications
  13.4.3 Laboratoires Servier Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Laboratoires Servier Main Business Overview
  13.4.5 Laboratoires Servier Latest Developments
13.5 Teva
  13.5.1 Teva Company Information
  13.5.2 Teva Buspirone Product Portfolios and Specifications
  13.5.3 Teva Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Teva Main Business Overview
  13.5.5 Teva Latest Developments
13.6 AMAG Pharmaceuticals
  13.6.1 AMAG Pharmaceuticals Company Information
  13.6.2 AMAG Pharmaceuticals Buspirone Product Portfolios and Specifications
  13.6.3 AMAG Pharmaceuticals Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 AMAG Pharmaceuticals Main Business Overview
  13.6.5 AMAG Pharmaceuticals Latest Developments
13.7 Mylan
  13.7.1 Mylan Company Information
  13.7.2 Mylan Buspirone Product Portfolios and Specifications
  13.7.3 Mylan Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Mylan Main Business Overview
  13.7.5 Mylan Latest Developments
13.8 Novartis
  13.8.1 Novartis Company Information
  13.8.2 Novartis Buspirone Product Portfolios and Specifications
  13.8.3 Novartis Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Novartis Main Business Overview
  13.8.5 Novartis Latest Developments
13.9 Watson Laboratories
  13.9.1 Watson Laboratories Company Information
  13.9.2 Watson Laboratories Buspirone Product Portfolios and Specifications
  13.9.3 Watson Laboratories Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Watson Laboratories Main Business Overview
  13.9.5 Watson Laboratories Latest Developments
13.10 Hikma
  13.10.1 Hikma Company Information
  13.10.2 Hikma Buspirone Product Portfolios and Specifications
  13.10.3 Hikma Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Hikma Main Business Overview
  13.10.5 Hikma Latest Developments
13.11 Wockhardt
  13.11.1 Wockhardt Company Information
  13.11.2 Wockhardt Buspirone Product Portfolios and Specifications
  13.11.3 Wockhardt Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Wockhardt Main Business Overview
  13.11.5 Wockhardt Latest Developments
13.12 Cadila Healthcare
  13.12.1 Cadila Healthcare Company Information
  13.12.2 Cadila Healthcare Buspirone Product Portfolios and Specifications
  13.12.3 Cadila Healthcare Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Cadila Healthcare Main Business Overview
  13.12.5 Cadila Healthcare Latest Developments
13.13 Orion Corporation
  13.13.1 Orion Corporation Company Information
  13.13.2 Orion Corporation Buspirone Product Portfolios and Specifications
  13.13.3 Orion Corporation Buspirone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Orion Corporation Main Business Overview
  13.13.5 Orion Corporation Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Buspirone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Buspirone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 5mg
Table 4. Major Players of 10mg
Table 5. Major Players of 15mg
Table 6. Major Players of 30mg
Table 7. Global Buspirone Sales by Type (2018-2023) & (K Units)
Table 8. Global Buspirone Sales Market Share by Type (2018-2023)
Table 9. Global Buspirone Revenue by Type (2018-2023) & ($ million)
Table 10. Global Buspirone Revenue Market Share by Type (2018-2023)
Table 11. Global Buspirone Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Buspirone Sales by Application (2018-2023) & (K Units)
Table 13. Global Buspirone Sales Market Share by Application (2018-2023)
Table 14. Global Buspirone Revenue by Application (2018-2023)
Table 15. Global Buspirone Revenue Market Share by Application (2018-2023)
Table 16. Global Buspirone Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Buspirone Sales by Company (2018-2023) & (K Units)
Table 18. Global Buspirone Sales Market Share by Company (2018-2023)
Table 19. Global Buspirone Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Buspirone Revenue Market Share by Company (2018-2023)
Table 21. Global Buspirone Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Buspirone Producing Area Distribution and Sales Area
Table 23. Players Buspirone Products Offered
Table 24. Buspirone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Buspirone Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Buspirone Sales Market Share Geographic Region (2018-2023)
Table 29. Global Buspirone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Buspirone Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Buspirone Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Buspirone Sales Market Share by Country/Region (2018-2023)
Table 33. Global Buspirone Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Buspirone Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Buspirone Sales by Country (2018-2023) & (K Units)
Table 36. Americas Buspirone Sales Market Share by Country (2018-2023)
Table 37. Americas Buspirone Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Buspirone Revenue Market Share by Country (2018-2023)
Table 39. Americas Buspirone Sales by Type (2018-2023) & (K Units)
Table 40. Americas Buspirone Sales by Application (2018-2023) & (K Units)
Table 41. APAC Buspirone Sales by Region (2018-2023) & (K Units)
Table 42. APAC Buspirone Sales Market Share by Region (2018-2023)
Table 43. APAC Buspirone Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Buspirone Revenue Market Share by Region (2018-2023)
Table 45. APAC Buspirone Sales by Type (2018-2023) & (K Units)
Table 46. APAC Buspirone Sales by Application (2018-2023) & (K Units)
Table 47. Europe Buspirone Sales by Country (2018-2023) & (K Units)
Table 48. Europe Buspirone Sales Market Share by Country (2018-2023)
Table 49. Europe Buspirone Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Buspirone Revenue Market Share by Country (2018-2023)
Table 51. Europe Buspirone Sales by Type (2018-2023) & (K Units)
Table 52. Europe Buspirone Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Buspirone Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Buspirone Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Buspirone Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Buspirone Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Buspirone Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Buspirone Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Buspirone
Table 60. Key Market Challenges & Risks of Buspirone
Table 61. Key Industry Trends of Buspirone
Table 62. Buspirone Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Buspirone Distributors List
Table 65. Buspirone Customer List
Table 66. Global Buspirone Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Buspirone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Buspirone Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Buspirone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Buspirone Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Buspirone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Buspirone Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Buspirone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Buspirone Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Buspirone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Buspirone Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Buspirone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Buspirone Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Buspirone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Bristol Myers Squibb Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 81. Bristol Myers Squibb Buspirone Product Portfolios and Specifications
Table 82. Bristol Myers Squibb Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Bristol Myers Squibb Main Business
Table 84. Bristol Myers Squibb Latest Developments
Table 85. Apotex Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 86. Apotex Buspirone Product Portfolios and Specifications
Table 87. Apotex Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Apotex Main Business
Table 89. Apotex Latest Developments
Table 90. Dr. Reddy's Laboratories Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 91. Dr. Reddy's Laboratories Buspirone Product Portfolios and Specifications
Table 92. Dr. Reddy's Laboratories Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Dr. Reddy's Laboratories Main Business
Table 94. Dr. Reddy's Laboratories Latest Developments
Table 95. Laboratoires Servier Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 96. Laboratoires Servier Buspirone Product Portfolios and Specifications
Table 97. Laboratoires Servier Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Laboratoires Servier Main Business
Table 99. Laboratoires Servier Latest Developments
Table 100. Teva Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 101. Teva Buspirone Product Portfolios and Specifications
Table 102. Teva Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Teva Main Business
Table 104. Teva Latest Developments
Table 105. AMAG Pharmaceuticals Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 106. AMAG Pharmaceuticals Buspirone Product Portfolios and Specifications
Table 107. AMAG Pharmaceuticals Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AMAG Pharmaceuticals Main Business
Table 109. AMAG Pharmaceuticals Latest Developments
Table 110. Mylan Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 111. Mylan Buspirone Product Portfolios and Specifications
Table 112. Mylan Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Mylan Main Business
Table 114. Mylan Latest Developments
Table 115. Novartis Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 116. Novartis Buspirone Product Portfolios and Specifications
Table 117. Novartis Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Novartis Main Business
Table 119. Novartis Latest Developments
Table 120. Watson Laboratories Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 121. Watson Laboratories Buspirone Product Portfolios and Specifications
Table 122. Watson Laboratories Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Watson Laboratories Main Business
Table 124. Watson Laboratories Latest Developments
Table 125. Hikma Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 126. Hikma Buspirone Product Portfolios and Specifications
Table 127. Hikma Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Hikma Main Business
Table 129. Hikma Latest Developments
Table 130. Wockhardt Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 131. Wockhardt Buspirone Product Portfolios and Specifications
Table 132. Wockhardt Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Wockhardt Main Business
Table 134. Wockhardt Latest Developments
Table 135. Cadila Healthcare Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 136. Cadila Healthcare Buspirone Product Portfolios and Specifications
Table 137. Cadila Healthcare Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Cadila Healthcare Main Business
Table 139. Cadila Healthcare Latest Developments
Table 140. Orion Corporation Basic Information, Buspirone Manufacturing Base, Sales Area and Its Competitors
Table 141. Orion Corporation Buspirone Product Portfolios and Specifications
Table 142. Orion Corporation Buspirone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Orion Corporation Main Business
Table 144. Orion Corporation Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Buspirone
Figure 2. Buspirone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Buspirone Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Buspirone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Buspirone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 5mg
Figure 10. Product Picture of 10mg
Figure 11. Product Picture of 15mg
Figure 12. Product Picture of 30mg
Figure 13. Global Buspirone Sales Market Share by Type in 2022
Figure 14. Global Buspirone Revenue Market Share by Type (2018-2023)
Figure 15. Buspirone Consumed in Hospital
Figure 16. Global Buspirone Market: Hospital (2018-2023) & (K Units)
Figure 17. Buspirone Consumed in Drug Store
Figure 18. Global Buspirone Market: Drug Store (2018-2023) & (K Units)
Figure 19. Global Buspirone Sales Market Share by Application (2022)
Figure 20. Global Buspirone Revenue Market Share by Application in 2022
Figure 21. Buspirone Sales Market by Company in 2022 (K Units)
Figure 22. Global Buspirone Sales Market Share by Company in 2022
Figure 23. Buspirone Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Buspirone Revenue Market Share by Company in 2022
Figure 25. Global Buspirone Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Buspirone Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Buspirone Sales 2018-2023 (K Units)
Figure 28. Americas Buspirone Revenue 2018-2023 ($ Millions)
Figure 29. APAC Buspirone Sales 2018-2023 (K Units)
Figure 30. APAC Buspirone Revenue 2018-2023 ($ Millions)
Figure 31. Europe Buspirone Sales 2018-2023 (K Units)
Figure 32. Europe Buspirone Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Buspirone Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Buspirone Revenue 2018-2023 ($ Millions)
Figure 35. Americas Buspirone Sales Market Share by Country in 2022
Figure 36. Americas Buspirone Revenue Market Share by Country in 2022
Figure 37. Americas Buspirone Sales Market Share by Type (2018-2023)
Figure 38. Americas Buspirone Sales Market Share by Application (2018-2023)
Figure 39. United States Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Buspirone Sales Market Share by Region in 2022
Figure 44. APAC Buspirone Revenue Market Share by Regions in 2022
Figure 45. APAC Buspirone Sales Market Share by Type (2018-2023)
Figure 46. APAC Buspirone Sales Market Share by Application (2018-2023)
Figure 47. China Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Buspirone Sales Market Share by Country in 2022
Figure 55. Europe Buspirone Revenue Market Share by Country in 2022
Figure 56. Europe Buspirone Sales Market Share by Type (2018-2023)
Figure 57. Europe Buspirone Sales Market Share by Application (2018-2023)
Figure 58. Germany Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Buspirone Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Buspirone Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Buspirone Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Buspirone Sales Market Share by Application (2018-2023)
Figure 67. Egypt Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Buspirone Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Buspirone in 2022
Figure 73. Manufacturing Process Analysis of Buspirone
Figure 74. Industry Chain Structure of Buspirone
Figure 75. Channels of Distribution
Figure 76. Global Buspirone Sales Market Forecast by Region (2024-2029)
Figure 77. Global Buspirone Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Buspirone Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Buspirone Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Buspirone Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Buspirone Revenue Market Share Forecast by Application (2024-2029)